tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KALA Stock Latest News

Kala Pharmaceuticals: Promising Clinical Developments and Financial Stability Support Buy Rating
RatingsKala Pharmaceuticals: Promising Clinical Developments and Financial Stability Support Buy Rating
5d ago
KALA
Kala Pharmaceuticals management to meet with Oppenheimer
PremiumThe Fly
Kala Pharmaceuticals management to meet with Oppenheimer
7d ago
KALA
KALA BIO Advances Eye Disease Therapies with New Funding
PremiumCompany Announcements
KALA BIO Advances Eye Disease Therapies with New Funding
9d ago
KALA
Kala Pharmaceuticals reports Q4 EPS ($1.74) vs. ($3.18) last year
PremiumThe Fly
Kala Pharmaceuticals reports Q4 EPS ($1.74) vs. ($3.18) last year
9d ago
KALA
Kala Pharmaceuticals sees cash runway into 1Q26
PremiumThe Fly
Kala Pharmaceuticals sees cash runway into 1Q26
9d ago
KALA
KALA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsKALA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
15d ago
KALA
Kala announces resignation of CEO Iwicki, Bazemore appointed interim CEO
Premium
The Fly
Kala announces resignation of CEO Iwicki, Bazemore appointed interim CEO
2M ago
KALA
Kala Pharmaceuticals files to sell 1.67M shares of common stock for holders
Premium
The Fly
Kala Pharmaceuticals files to sell 1.67M shares of common stock for holders
2M ago
KALA
Kala Bio to sell 1.34M shares at $6.44 in private placement
PremiumThe Fly
Kala Bio to sell 1.34M shares at $6.44 in private placement
3M ago
KALA
Kala Bio Advances PCED Treatment Amid Financial Update
PremiumCompany Announcements
Kala Bio Advances PCED Treatment Amid Financial Update
5M ago
KALA
Kala Pharmaceuticals reports Q3 EPS ($1.93) vs ($3.41) last year
PremiumThe Fly
Kala Pharmaceuticals reports Q3 EPS ($1.93) vs ($3.41) last year
5M ago
KALA
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
PremiumCompany Announcements
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
7M ago
8K
KALA
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
PremiumThe FlyOppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
8M ago
KALA
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
Premium
The Fly
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
8M ago
KALA
Kala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
Premium
The Fly
Kala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
8M ago
KALA
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
PremiumThe Fly
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
9M ago
KALA
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
PremiumThe Fly
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
10M ago
KALA
Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
11M ago
KALA
Kala Pharmaceuticals reports Q1 EPS ($4.20), consensus ($(2.89)
PremiumThe Fly
Kala Pharmaceuticals reports Q1 EPS ($4.20), consensus ($(2.89)
11M ago
KALA
Kala Pharmaceuticals price target lowered to $21 from $22 at H.C. Wainwright
PremiumThe FlyKala Pharmaceuticals price target lowered to $21 from $22 at H.C. Wainwright
1y ago
KALA
KALA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KALA Earnings this Week: How Will it Perform?
1y ago
KALA
KALA Pharmaceuticals Spotlights Ophthalmology Advances
Premium
Company Announcements
KALA Pharmaceuticals Spotlights Ophthalmology Advances
1y ago
8K
KALA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >